Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatum

[1]  H. Benveniste,et al.  Determination of Brain Interstitial Concentrations by Microdialysis , 1989, Journal of neurochemistry.

[2]  R. Wurtman,et al.  Tyrosine: Effects on catecholamine release , 1988, Brain Research Bulletin.

[3]  H. Benveniste,et al.  Regional Cerebral Glucose Phosphorylation and Blood Flow After Insertion of a Microdialysis Fiber Through the Dorsal Hippocampus in the Rat , 1987, Journal of neurochemistry.

[4]  J. Cedarbaum.  Clinical Pharmacokinetics of Anti-Parkinsonian Drugs , 1987, Clinical pharmacokinetics.

[5]  U. Ungerstedt,et al.  Microdialysis in the study of extracellular levels of amino acids in the rat brain. , 1986, Acta physiologica Scandinavica.

[6]  J. Tuomisto,et al.  Neurotransmitter regulation of anterior pituitary hormones. , 1985, Pharmacological reviews.

[7]  Stéphane Huot,et al.  Simultaneous Determination of 3,4‐Dihydroxyphenylalanine, 5‐Hydroxytryptophan, Dopamine, 4‐Hydroxy‐3‐Methoxyphenylalanine, Norepinephrine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5‐Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High‐Performance Liquid Chro , 1982, Journal of neurochemistry.

[8]  R. Wurtman,et al.  Carbidopa elevates hypothalamic dopa and serum prolactin in rats. , 1979, Life sciences.

[9]  W. Dewhurst,et al.  Blood‐brain barrier to carbidopa (MK‐486) and Ro 4–4602, peripheral dopa decarboxylase inhibitors , 1973, The Journal of pharmacy and pharmacology.

[10]  R. Baldessarini.  Inhibition of catechol‐O‐methyl transferase by l‐dopa and decarboxylase inhibitors , 1972, The Journal of pharmacy and pharmacology.

[11]  R. Baldessarini,et al.  Effects of L-dopa on norepinephrine metabolism in the brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[12]  V. J. Lotti,et al.  Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors. , 1970, The Journal of pharmacology and experimental therapeutics.

[13]  S. Heisey.  Brain and choroid plexus blood volumes in vertebrates. , 1968, Comparative Biochemistry and Physiology A.

[14]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[15]  A. Saija,et al.  Aging and sex influence the permeability of the blood-brain barrier in the rat. , 1990, Life sciences.

[16]  S. Kaakkola,et al.  Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[17]  P. LeWitt.  The Pharmacology of Levodopa in Treatment of Parkinson’s Disease: An Update , 1989 .

[18]  W. Haefely,et al.  Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. , 1987, European neurology.